[1] |
GELLATLY S L,HANCOCK R E W.Pseudomonas aeruginosa:new insights into pathogenesis and host defenses[J].Pathog Dis,2013,67(3):159-173.
|
[2] |
陈晨.貂源绿脓杆菌的分离鉴定及其致病性研究[D].泰安:山东农业大学,2015.CHEN C.Identification and pathogenicity test of Pseudomonas aeruginosa from mink[D].Taian:Shandong Agricultural University,2015.(in Chinese)
|
[3] |
朱利霞,王洪彬,杨楠,等.水貂绿脓杆菌病研究概述[J].黑龙江畜牧兽医,2018(18):214-217.ZHU L X,WANG H B,YANG N,et al.Summary of research on Pseudomonas aeruginosa in mink[J].Heilongjiang Animal Science and Veterinary Medicine,2018(18):214-217.(in Chinese)
|
[4] |
LYCZAK J B,CANNON C L,PIER G B.Establishment of Pseudomonas aeruginosa infection:lessons from a versatile opportunist[J].Microbes Infect,2000,2(9):1051-1060.
|
[5] |
GALE M J,MARITATO M S,CHEN Y L,et al.Pseudomonas aeruginosa causing inflammatory mass of the nasopharynx in an immunocompromised HIV infected patient:a mimic of malignancy[J].IDCases,2015,2(2):40-43.
|
[6] |
GOMILA A,CARRATALÀ J,BADIA J M,et al.Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery:a multicenter prospective cohort study[J].BMC Infect Dis,2018,18(1):507.
|
[7] |
THI M T T,WIBOWO D,REHM B H A.Pseudomonas aeruginosa Biofilms[J].Int J Mol Sci,2020,21(22):8671.
|
[8] |
LIM K H,STAUDT L M.Toll-like receptor signaling[J].Cold Spring Harb Perspect Biol,2013,5(1):a011247.
|
[9] |
OLIVEIRA J,REYGAERT W C.Gram negative bacteria[M]//StatPearls.Treasure Island (FL):StatPearls Publishing,2021.
|
[10] |
DING J Y,LIU Q Q.Toll-like receptor 4:a promising therapeutic target for pneumonia caused by Gram-negative bacteria[J].J Cell Mol Med,2019,23(9):5868-5875.
|
[11] |
JUAREZ E,NUÑEZ C,SADA E,et al.Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes[J].Respir Res,2010,11:2.
|
[12] |
KURAHASHI K,KAJIKAWA O,SAWA T,et al.Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia[J].J Clin Invest,1999,104(6):743-750.
|
[13] |
SU Y F,YAO H,WANG H,et al.IL-27 enhances innate immunity of human pulmonary fibroblasts and epithelial cells through upregulation of TLR4 expression[J].Am J Physiol Lung Cell Mol Physiol,2016,310(2):L133-L141.
|
[14] |
GHAZI E,SONTHEIMER R D,WERTH V P.The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum[J].Clin Exp Rheumatol,2013,31(1):128-134.
|
[15] |
CHALK K,MEISEL C,SPIES C,et al.Dysfunction of alveolar macrophages after cardiac surgery and postoperative pneumonia?-an observational study[J].Crit Care,2013,17(6):R285.
|
[16] |
BEG A A.Endogenous ligands of Toll-like receptors:implications for regulating inflammatory and immune responses[J].Trends Immunol,2002,23(11):509-512.
|
[17] |
ZAMYATINA A,HEINE H.Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4/11 mediated inflammatory pathways[J].Front Immunol,2020,11:585146.
|
[18] |
BEUTLER B,RIETSCHEL E T.Innate immune sensing and its roots:the story of endotoxin[J].Nat Rev Immunol,2003,3(2):169-176.
|
[19] |
SCHOENFELD H J,POESCHL B,FREY J R,et al.Efficient purification of recombinant human tumor necrosis factor-β from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors[J].J Biol Chem,1991,266(6):3863-3869.
|
[20] |
KURT-JONES E A,POPOVA L,KWINN L,et al.Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus[J].Nat Immunol,2000,1(5):398-401.
|
[21] |
FIERS W.Tumor necrosis factor characterization at the molecular,cellular and in vivo level[J].FEBS Lett,1991,285(2):199-212.
|
[22] |
GREBE A,HOSS F,LATZ E.NLRP3 inflammasome and the IL-1 pathway in atherosclerosis[J].Circ Res,2018,122(12):1722-1740.
|
[23] |
CONTI P,CARAFFA A,GALLENGA C E,et al.Coronavirus-19(SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19:a promising inhibitory strategy[J].J Biol Regul Homeost Agents,2020,34(6):1971-1975.
|
[24] |
KANEKO N,KURATA M,YAMAMOTO T,et al.The role of interleukin-1 in general pathology[J].Inflamm Regen,2019,39:12.
|
[25] |
ALEXANDER C M,XIONG K N,VELMURUGAN K,et al.Differential innate immune cell signatures and effects regulated by toll-like receptor 4 during murine lung tumor promotion[J].Exp Lung Res,2016,42(3):154-173.
|
[26] |
SKJESOL A,YURCHENKO M,BÖSL K,et al.The TLR4 adaptor TRAM controls the phagocytosis of Gram-negative bacteria by interacting with the Rab11-family interacting protein 2[J].PLoS Pathog,2019,15(3):e1007684.
|
[27] |
THOMPSON M R,KAMINSKI J J,Kurt-Jones E A,et al.Pattern recognition receptors and the innate immune response to viral infection[J].Viruses,2011,3(6):920-940.
|
[28] |
DZIARSKI R,GUPTA D.How innate immunity proteins kill bacteria and why they are not prone to resistance[J].Curr Genet,2018,64(1):125-129.
|
[29] |
BONILLA F A,OETTGEN H C.Adaptive immunity[J].J Allergy Clin Immunol,2010,125(2 Suppl 2):S33-S40.
|
[30] |
WONG J J M,LEONG J Y,LEE J H,et al.Insights into the immuno-pathogenesis of acute respiratory distress syndrome[J].Ann Transl Med,2019,7(19):504.
|
[31] |
SANTIESTEBAN-LORES L E,AMAMURA T A,DA SILVA T F,et al.A double edged-sword-The Complement System during SARS-CoV-2 infection[J].Life Sci,2021,272:119245.
|
[32] |
MOKRA D,KOSUTOVA P.Biomarkers in acute lung injury[J].Respir Physiol Neurobiol,2015,209:52-58.
|
[33] |
GONZÁLEZ-LÓPEZ A,ALBAICETA G M.Repair after acute lung injury:molecular mechanisms and therapeutic opportunities[J].Crit Care,2012,16(2):209.
|
[34] |
MEDZHITOV R,SCHNEIDER D S,SOARES M P.Disease tolerance as a defense strategy[J].Science,2012,335(6071):936-941.
|